The regulatory network of B‐cell differentiation: a focused view of early B‐cell factor 1 function

Immunological Reviews - Tập 261 Số 1 - Trang 102-115 - 2014
Sören Boller1, Rudolf Grosschedl1
1Department of Cellular and Molecular Immunology, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany

Tóm tắt

Summary

During the last decades, many studies have investigated the transcriptional and epigenetic regulation of lineage decision in the hematopoietic system. These efforts led to a model in which extrinsic signals and intrinsic cues establish a permissive chromatin context upon which a regulatory network of transcription factors and epigenetic modifiers act to guide the differentiation of hematopoietic lineages. These networks include lineage‐specific factors that further modify the epigenetic landscape and promote the generation of specific cell types. The process of B lymphopoiesis requires a set of transcription factors, including Ikaros, PU.1, E2A, and FoxO1 to ‘prime’ cis‐regulatory regions for subsequent activation by the B‐lineage‐specific transcription factors EBF1 and Pax‐5. The expression of EBF1 is initiated by the combined action of E2A and FoxO1, and it is further enhanced and maintained by several positive feedback loops that include Pax‐5 and IL‐7 signaling. EBF1 acts in concert with Ikaros, PU.1, Runx1, E2A, FoxO1, and Pax‐5 to establish the B cell‐specific transcription profile. EBF1 and Pax‐5 also collaborate to repress alternative cell fates and lock cells into the B‐lineage fate. In addition to the functions of EBF1 in establishing and maintaining B‐cell identity, EBF1 is required to coordinate differentiation with cell proliferation and survival.

Từ khóa


Tài liệu tham khảo

10.1146/annurev.immunol.19.1.595

10.1016/j.coi.2010.01.010

10.1016/j.immuni.2007.05.013

10.1038/nri2234

10.1007/s00223-013-9753-3

10.1016/j.immuni.2007.05.010

10.1016/j.coi.2010.02.003

10.1111/j.1600-065X.2010.00950.x

10.1016/j.immuni.2011.06.013

10.1101/gad.1602607

10.1016/j.stem.2007.07.004

10.1038/35004599

10.1016/j.cell.2005.02.013

10.1084/jem.20060697

10.1016/S0092-8674(00)80453-5

10.1182/blood-2007-11-125385

10.1101/gad.1836009

10.1084/jem.189.4.735

10.1016/j.smim.2005.12.001

10.1111/j.0105-2896.2004.0101.x

10.1196/annals.1313.119

10.1002/j.1460-2075.1991.tb04905.x

10.1101/gad.7.5.760

10.1128/MCB.13.6.3392

10.1038/364121a0

10.1128/MCB.13.5.3002

10.1016/S0925-4773(01)00486-5

10.1128/MCB.22.24.8389-8397.2002

10.1002/j.1460-2075.1995.tb07290.x

10.1016/j.molimm.2008.05.018

10.1101/gad.1976610

10.1074/jbc.C110.150482

10.1016/S0968-0004(99)01416-4

10.1016/0014-5793(95)00541-G

10.1016/S0969-2126(99)80002-1

Wang SS, 1997, The characterization of the Olf‐1/EBF‐like HLH transcription factor family: implications in olfactory gene regulation and neuronal development, J Neurosci, 17, 4149, 10.1523/JNEUROSCI.17-11-04149.1997

10.1006/mcne.2002.1138

10.1016/j.it.2005.07.001

10.1016/0092-8674(94)90159-7

10.1016/j.immuni.2010.04.013

10.1038/ni.1891

10.1101/gad.187328.112

10.1038/ni1119

10.1128/MCB.22.24.8539-8551.2002

10.1128/MCB.23.6.1946-1960.2003

10.1038/ncomms3166

10.1073/pnas.0809485106

10.1128/MCB.00819-12

10.1523/JNEUROSCI.17-11-04159.1997

10.1182/blood-2003-07-2388

10.1128/MCB.18.11.6447

10.1084/jem.20130497

10.1182/blood-2002-08-2652

10.4161/cc.10.13.16045

10.1371/journal.pbio.1001433

10.1128/MCB.01557-06

10.1074/jbc.M113.491936

10.1101/gad.11.6.774

10.1016/j.stem.2010.07.016

10.1038/emboj.2012.275

10.1084/jem.190.9.1201

10.1016/j.febslet.2010.09.042

10.1016/S1074-7613(00)80034-5

10.1128/MCB.20.20.7572-7582.2000

10.1038/ni1314

10.1038/ni.1626

10.1084/jem.20131735

10.4049/jimmunol.1003794

10.1182/blood-2012-08-450114

10.1038/ni.2828

10.1038/onc.2011.597

10.1016/j.immuni.2009.07.011

10.1111/j.1600-065X.2010.00955.x

10.1002/j.1460-2075.1996.tb00949.x

10.1126/science.288.5470.1439

10.1128/MCB.14.1.373

10.1074/jbc.M700377200

10.1016/S1074-7613(02)00269-8

10.1016/j.devcel.2004.08.006

10.1016/j.molcel.2010.05.004

10.1016/0092-8674(94)90076-0

10.1016/0092-8674(94)90077-9

10.1073/pnas.0808866106

10.4049/jimmunol.181.9.5885

10.1016/j.immuni.2008.05.015

10.1182/blood-2008-11-191890

10.1016/j.smim.2008.05.003

10.1182/blood-2009-08-239210

10.1016/j.immuni.2010.11.028

10.1038/ni925

10.1038/376263a0

10.1016/0092-8674(94)90079-5

10.1182/blood-2009-08-236398

10.1146/annurev-immunol-032712-100024

10.1084/jem.20032202

10.1084/jem.20090756

10.4049/jimmunol.169.1.261

10.1128/MCB.01192-06

10.1084/jem.20050158

10.1084/jem.20112745

10.4049/jimmunol.1103390

10.1016/j.immuni.2011.11.010

10.1073/pnas.1211427109

10.1084/jem.188.4.699

10.1073/pnas.1111766108

10.1038/ni.1667

10.1016/j.immuni.2009.01.012

Hagman J, 2012, B lymphocyte lineage specification, commitment and epigenetic control of transcription by early B cell factor 1, Curr Top Microbiol Immunol, 356, 17

10.1084/jem.20112422

10.1038/ni1555

10.1093/emboj/cdg464

10.1128/MCB.19.1.392

10.1016/S0161-5890(99)00092-9

Akerblad P, 1999, Early B cell factor is an activator of the B lymphoid kinase promoter in early B cell development, J Immunol, 163, 5453, 10.4049/jimmunol.163.10.5453

10.1016/S1074-7613(00)80507-5

10.1016/S1074-7613(00)80078-3

10.4049/jimmunol.181.5.3364

10.1128/MCB.20.10.3640-3654.2000

10.4049/jimmunol.168.10.5130

10.1073/pnas.1003525107

10.1101/gad.1031403

10.1101/gad.11.4.476

10.1038/44076

10.1073/pnas.1210144109

10.1038/44164

10.1038/nature06159

10.1016/j.immuni.2006.01.012

10.1016/S1074-7613(02)00472-7

10.1016/j.immuni.2013.01.014

10.1038/ni.2641

10.1038/nature10279

10.1002/(SICI)1521-4141(199906)29:06<1912::AID-IMMU1912>3.0.CO;2-D

10.1016/j.immuni.2011.08.007

10.1073/pnas.0802550106

10.1038/nrc3638

10.1016/j.coi.2012.04.004

10.1038/nri3365

10.1016/j.stem.2009.10.004